Company intelligence / Profile preview

Bio SB

Goleta, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Bio SB is a commercial-stage biotech company specializing in the research, development, and production of antibodies and detection systems for immunohistochemistry (IHC) and related technologies. The company’s products are used globally in cancer diagnostics, infectious disease detection, and predictive decision-making in pathology. They manufacture over 460 IVD antibodies with international regulatory certifications and serve clinical and research labs in more than 70 countries.[1][2][3][4]

Therapeutic areas: OncologyInfectious Diseases
Modalities: AntibodyRecombinant proteinDetection system
Industry: Pathology

Beyond the preview

Go deeper on Bio SB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio SB.

Explore the full profile